Ihuman Other Current Liab from 2010 to 2025

IH Stock  USD 2.05  0.18  9.63%   
Ihuman's Other Current Liabilities is increasing with slightly volatile movements from year to year. Other Current Liabilities is estimated to finish at about 528.8 M this year. For the period between 2010 and 2025, Ihuman, Other Current Liabilities quarterly trend regression had mean deviation of  125,234,860 and range of 528 M. View All Fundamentals
 
Other Current Liabilities  
First Reported
2019-12-31
Previous Quarter
137.1 M
Current Value
167.2 M
Quarterly Volatility
87.7 M
 
Covid
Check Ihuman financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ihuman's main balance sheet or income statement drivers, such as Tax Provision of 40 M, Depreciation And Amortization of 14.1 M or Interest Expense of 13.1 M, as well as many indicators such as Price To Sales Ratio of 1.31, Dividend Yield of 0.0117 or PTB Ratio of 1.2. Ihuman financial statements analysis is a perfect complement when working with Ihuman Valuation or Volatility modules.
  
Check out the analysis of Ihuman Correlation against competitors.

Latest Ihuman's Other Current Liab Growth Pattern

Below is the plot of the Other Current Liab of Ihuman Inc over the last few years. It is Ihuman's Other Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Ihuman's overall financial position and show how it may be relating to other accounts over time.
Other Current Liab10 Years Trend
Slightly volatile
   Other Current Liab   
       Timeline  

Ihuman Other Current Liab Regression Statistics

Arithmetic Mean156,190,606
Geometric Mean88,570,277
Coefficient Of Variation107.73
Mean Deviation125,234,860
Median79,346,000
Standard Deviation168,260,506
Sample Variance28311.6T
Range528M
R-Value0.69
Mean Square Error15941.1T
R-Squared0.47
Significance0
Slope24,344,255
Total Sum of Squares424674T

Ihuman Other Current Liab History

2025528.8 M
2024503.7 M
2023438 M
2022118.8 M
2021104.7 M
202090.1 M
2019880 K

About Ihuman Financial Statements

Investors use fundamental indicators, such as Ihuman's Other Current Liab, to determine how well the company is positioned to perform in the future. Although Ihuman's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Other Current Liabilities503.7 M528.8 M

Currently Active Assets on Macroaxis

Check out the analysis of Ihuman Correlation against competitors.
You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Is Hotels, Restaurants & Leisure space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ihuman. If investors know Ihuman will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ihuman listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.53)
Earnings Share
0.27
Revenue Per Share
17.883
Quarterly Revenue Growth
(0.08)
Return On Assets
0.0348
The market value of Ihuman Inc is measured differently than its book value, which is the value of Ihuman that is recorded on the company's balance sheet. Investors also form their own opinion of Ihuman's value that differs from its market value or its book value, called intrinsic value, which is Ihuman's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ihuman's market value can be influenced by many factors that don't directly affect Ihuman's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ihuman's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ihuman is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ihuman's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.